Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Ardianto et al
Risk of hepatic events associated with use of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists, and thiazolidinediones among patients with metabolic dysfunction-associated steatotic liver disease
1 Glutathione Brand 1
Limitations of RCTs presented in Table 2 and Table 3 The side effects reported at the end of a clinical trial may be partially distorted due to gastrointestinal problems if the study is stopped too early [127]
US$ 29.57
US$ 23.49
US$ 29.21
US$ 28.88
US$ 24.19
US$ 24.82
